Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xontogeny is a Boston-based life sciences accelerator that partners with entrepreneurs and scientific founders to advance early-stage technologies—therapeutics, diagnostics, and devices—toward clinical proof-of-concept. It provides seed investment capital, operational support from experienced industry professionals, and access to a broad network of consultants and service providers. The company’s model emphasizes efficient development strategies and leverages partnerships such as the Perceptive Xontogeny Venture Fund for Series A/B financing. Its pipeline consists of investments in numerous early-stage biotech ventures across diverse modalities and disease areas but does not develop its own drugs or products directly.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xontogeny.